Suppr超能文献

益生菌混合物通过对脂质谱、瘦素和炎症生物标志物的作用改善脂肪肝疾病。

Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers.

作者信息

Al-Muzafar Hessah Mohammed, Amin Kamal Adel

机构信息

Department of Chemistry, Faculty of Science, University of Imam Abdulrahman Alfaisal (Dammam), P.O. 383, Dammam, 31113, Saudi Arabia.

出版信息

BMC Complement Altern Med. 2017 Jan 13;17(1):43. doi: 10.1186/s12906-016-1540-z.

Abstract

BACKGROUND

A high fat diet has an essential role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). This condition is characterized by hepatic fat accumulation (steatosis) and is associated with obesity, diabetes, and fibrosis or cirrhosis of the liver. Probiotics may be useful in the treatment of steatosis. This study examined the effects of an ingested probiotic formulation on the lipid profiles, liver functions, leptin levels, and inflammatory marker levels of rats with NAFLD that had been induced via high fat and sucrose diet (HFSD).

METHODS

Young male albino rats were randomly divided into three groups: a control group that was fed a standard diet; a second group that was fed a HFSD; and a third group that was given both a HFSD and ingestible probiotic mixtures. The groups were fed these diets for 16 weeks, and were then examined.

RESULTS

HFSD-only rats showed hypertriglyceridemia, hypercholesterolemia, and elevated low density lipoprotein (LDL) levels, and their serum alanine transaminase (ALT) and bilirubin levels were significantly higher than those of the control group. Compared to rats on the standard diet, HFSD-only rats showed higher levels of tumor necrosis factor alpha (TNF-α) and interleukin 6 (IL-6), increased serum leptin levels, and increased resistin hormone levels in the adipose tissues. In the third group, the inclusion of the probiotic mixture seemed to ameliorate the effects of the HFSD diet. The NAFD + probiotics group showed improved lipid profiles, better leptin and resistin levels, and better TNF-α and IL-6 levels than the NAFD-only group. They also showed no signs of NAFLD.

CONCLUSIONS

The probiotic mixture showed promise as a treatment for NAFLD pathogenesis, and may improve HFSD-induced steatosis through its effects on leptin, resistin, inflammatory biomarkers, and hepatic function markers. We also established that gut microbiota-mediated regulation of lipid profiles was dependent on dietary lipids and carbohydrates.

摘要

背景

高脂饮食在非酒精性脂肪性肝病(NAFLD)的发病机制中起重要作用。这种病症的特征是肝脏脂肪堆积(脂肪变性),并与肥胖、糖尿病以及肝脏纤维化或肝硬化有关。益生菌可能对脂肪变性的治疗有用。本研究检测了摄入的益生菌制剂对通过高脂高糖饮食(HFSD)诱导的NAFLD大鼠的血脂谱、肝功能、瘦素水平和炎症标志物水平的影响。

方法

将年轻雄性白化大鼠随机分为三组:一组喂食标准饮食作为对照组;第二组喂食HFSD;第三组既喂食HFSD又给予可摄入的益生菌混合物。这些组按这些饮食喂养16周,然后进行检测。

结果

仅喂食HFSD的大鼠出现高甘油三酯血症、高胆固醇血症和低密度脂蛋白(LDL)水平升高,并且它们的血清丙氨酸转氨酶(ALT)和胆红素水平显著高于对照组。与喂食标准饮食的大鼠相比,仅喂食HFSD的大鼠肿瘤坏死因子α(TNF-α)和白细胞介素6(IL-6)水平更高,血清瘦素水平升高,脂肪组织中抵抗素激素水平增加。在第三组中,添加益生菌混合物似乎改善了HFSD饮食的影响。与仅患NAFD的组相比,NAFD +益生菌组的血脂谱得到改善,瘦素和抵抗素水平更好,TNF-α和IL-6水平也更好。它们也没有NAFLD的迹象。

结论

益生菌混合物有望用于治疗NAFLD发病机制,并且可能通过其对瘦素、抵抗素、炎症生物标志物和肝功能标志物的作用改善HFSD诱导的脂肪变性。我们还确定肠道微生物群介导的血脂谱调节取决于膳食脂质和碳水化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca7/5237220/af102627fa8d/12906_2016_1540_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验